To confirm whether Bcl-2 promoter polymorphisms are related to cancer, we performed this meta-analysis, aiming to measure the correlation between Bcl-2 promoter polymorphisms and cancer susceptibility and prognosis. The gene discussed is BCL2; the disease is cancer.